Showing results (1431-1440 of 1,880) with videos related to
Sort By:
Pageof 188
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM groupM Martin, A Villar, A Sole-Calvo, et al.Semergen|July 22, 2014
[Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document]Pedro Mata, Rodrigo Alonso, Antonio Ruiz, et al.Skeletal Radiology|January 17, 2026
Accessible cartilage tumor malignancy prediction via vision-language foundation model adaptationXingxin He, Zachary E Stewart, Marcos R Gonzalez, et al.Antioxidants (Basel, Switzerland)|April 30, 2021
Melatonin Modulates the Antioxidant Defenses and the Expression of Proinflammatory Mediators in Pancreatic Stellate Cells Subjected to HypoxiaMatias Estaras, Manuel R Gonzalez-Portillo, Remigio Martinez, et al.Nanoscale|October 8, 2011
Soft plasma processing of organic nanowires: a route for the fabrication of 1D organic heterostructures and the template synthesis of inorganic 1D nanostructuresMaria Alcaire, Juan R Sanchez-Valencia, Francisco J Aparicio, et al.European Heart Journal|February 26, 2009
The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failureRafael Vazquez, Antoni Bayes-Genis, Iwona Cygankiewicz, et al.Journal of Clinical Lipidology|June 7, 2025
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndromeAlberto Cordero, José R Gonzalez-Juanatey, Rosa Fernandez Olmo, et al.The American Journal of Cardiology|March 31, 2009
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, et al.Annals of Surgical Oncology|December 2, 2025
Long-Term Clinical and Functional Outcomes after Intercalary Allograft Reconstruction for Oncologic IndicationsMarcos R Gonzalez, Erhan Okay, Joseph O Werenski, et al.Drugs in Context|July 24, 2020
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trialJosé Luis Hernández, Francisco S Lozano, Vincent Riambau, et al.Pageof 188